指南与共识泌尿生殖MRUS

PI-RADS指导委员会:PI-RADS多参数MRI及MRI引导活检路径

PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.
PubMed 文献 · Radiology · 2019-06-11

高质量证据显示,在活检初治男性中,MRI可减少需要前列腺活检的人数并减少不太可能造成危害的临床无显著意义癌的诊断;对于既往活检阴性但仍持续怀疑者,MRI较系统经直肠超声引导活检改善危及生命前列腺癌的检出与定位;PI-RADS委员会讨论了如何将MRI路径纳入常规临床实践及面临的挑战。

要点

  • 活检初治男性中,MRI可减少需要前列腺活检的人数并减少临床无显著意义癌的诊断。
  • 既往活检阴性但仍持续怀疑者,MRI引导活检较系统经直肠超声引导活检改善危及生命前列腺癌的检出与定位。
  • PI-RADS已广泛用于多参数MRI采集、解读与报告,推动MRI引导活检路径纳入临床指南。

核心结论

  • 高质量证据表明,MRI在活检初治男性中可减少需要前列腺活检的人数并减少临床无显著意义癌的诊断。
  • 在既往活检阴性但仍持续怀疑的男性中,MRI较当前标准治疗(系统经直肠超声引导活检)改善危及生命前列腺癌的检出与定位,临床效用更高。
  • 系统分析显示,MRI引导活检提高前列腺癌诊断路径的有效性,将MRI引导路径纳入前列腺癌检测临床指南的工作已开始。

研究设计与样本

  • 本文为PI-RADS指导委员会讨论,基于高质量证据与系统分析,阐述MRI路径如何纳入常规临床实践及面临的挑战。

临床应用与阅片要点

  • PI-RADS指导委员会讨论了如何将MRI引导活检路径纳入常规临床实践,以向临床怀疑前列腺癌的男性传递关键诊断获益。
  • 委员会同时讨论了在提供临床显著前列腺癌疑似男性所需积极健康影响方面面临的挑战。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

High-quality evidence shows that MRI in biopsy-naive men can reduce the number of men who need prostate biopsy and can reduce the number of diagnoses of clinically insignificant cancers that are unlikely to cause harm. In men with prior negative biopsy results who remain under persistent suspicion, MRI improves the detection and localization of life-threatening prostate cancer with greater clinical utility than the current standard of care, systematic transrectal US-guided biopsy. Systematic analyses show that MRI-directed biopsy increases the effectiveness of the prostate cancer diagnosis pathway. The incorporation of MRI-directed pathways into clinical care guidelines in prostate cancer detection has begun. The widespread adoption of the Prostate Imaging Reporting and Data System (PI-RADS) for multiparametric MRI data acquisition, interpretation, and reporting has promoted these changes in practice. The PI-RADS MRI-directed biopsy pathway enables the delivery of key diagnostic benefits to men suspected of having cancer based on clinical suspicion. Herein, the PI-RADS Steering Committee discusses how the MRI pathway should be incorporated into routine clinical practice and the challenges in delivering the positive health impacts needed by men suspected of having clinically significant prostate cancer.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Padhani AR, Barentsz J, Villeirs G, et al. PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway. Radiology. 2019. PMID: 31184561. doi:10.1148/radiol.2019182946

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。